JFGIW
IOVA icon

Johnson Financial Group Inc (Wisconsin)’s Iovance Biotherapeutics IOVA Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$1.28K – 666
2022
Q4 		$1.28K Hold
200
– – ﹤0.01% 588
2022
Q3 		$2K Hold
200
– – ﹤0.01% 580
2022
Q2 		$2K Hold
200
– – ﹤0.01% 607
2022
Q1 		$3K Hold
200
– – ﹤0.01% 633
2021
Q4 		$4K Hold
200
– – ﹤0.01% 650
2021
Q3 		$5K Buy
+200
New +$4.71K ﹤0.01% 580

Other funds holding IOVA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s IOVA Position: Q1 2023 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Iovance Biotherapeutics (IOVA) in Q1 2023, closing a stake of 200 shares — an estimated $1.28K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in IOVA in Q3 2021 and held it in 6 quarters. The position peaked at $5K in Q3 2021. 228 funds tracked by Wall St. Rank hold IOVA as of Q1 2023.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Iovance Biotherapeutics position as of Q1 2023 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 200 Iovance Biotherapeutics shares in Q1 2023, an estimated $1.28K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Iovance Biotherapeutics in Q3 2021 and held it in 6 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Iovance Biotherapeutics position peaked at $5K in Q3 2021.
  • 228 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2023.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2023, filed 12 May 2023.